It can produce 20 kinds of chemical medicines 1.6 billion pills, 50 tons of 40 kinds of bulk drugs per year.
新浦厂区主要是固体制剂与原料药生产地，拥有2个通过 GMP认证的固体制剂车间、6个原料车间。
Shanghai Hengrui was in production in Jun. 2004
Shanghai Hengrui Campus
Sales Net
恒瑞有九个销售公司，在全国各地有80个办事处，
共有1500名销售代表
Sale network covers all of the country.
0 2001
2002
2003
2004
2005
R &D Activity 研究与开发
恒瑞拥有2个研究中心 Hengrui Has Two R&D Centers • 恒瑞连云港研究中心 Lianyungang R&D Center
人员Researcher and Engineer：130 Persons 化学合成、植物药、中试研究、通用名药物 Chemical Synthesizing, Plant Drugs, Scale Test Before
恒瑞现有两个厂区：新浦厂区 开发区新厂区
Workshop & Equipment
The Xinpu factory is the main area of synthesizing and producing bulk drugs, including two solid preparation which passed to GMP inspection and 6 bulk drugs workshops.
Top 5 Products in 2004
Unit:Million RMB
180 160 140 120 100
80 60 40 20 0 Aiheng
Tongao
Lelang Nuobang
Aisu
FDA Approving
● 2001年恒瑞医药原料药异环磷酰胺、足叶乙甙、美司那、噻 替派通过了美国FDA验证。
There are 62 sale offices inside China.
Salespersons are over 1300.
Active Pharmaceutical ingredients are mainly sold to USA and Europe.,
Jinagsu Hengrui Sales Status
Pharmaceuticals and R&D
Shanghai Hengrui Medicine & Chengdu Hengrui Medicine
成都☉
☉连云港
☉上海
Workshop & Equipment
Hengrui has two factory zones, the old one is located at Xinpu, the new one is located at ECO. & TECH Development Zone.
Freeze Dryer Imported from EDWARDS
Form-Fill-Seal Line
Solid Preparation Auto-Line
Auto-Packing Line
Subsidiary company －－Shanghai Hengrui
● 上海分公司2004年上半年建成投产。
Jiangsu Hengrui Medicine Co., Introduction
Jiangsu Hengrui Medicine Co., Ltd
江苏恒瑞医药股份有限公司
2006
Better medicines to people’s health
关爱人类健康
主讲人：
Jiangsu Hengrui Medicine
Ifosfamide, Etoposide, Mesna and Thiotepa were approved by FDA in 2001.
Export Status Of Raw Chemical Material
Unit: ￥Ten thousand(RMB)
6000 5000 4000 3000 2000 1000
R & D Activity 研究
植物药 Plant Drugs • 肝病治疗药Liver Treatment
Drugs • 镇咳药 Antitussivers • 妇科用药 Gynecological Drugs
生物工程 Biology Engineering 单克隆抗体
Monoclonal Antibody 多肽合成
谢谢
Established: 1970 Head Office: Lianyungang ,Jiangsu, China President: Mr.Piaoyang Sun Employees : 1800 including: R&D 230
恒瑞医药始建于1970年，公司位于江苏连云港 董事长 孙飘扬 公司现有员工2000人，研发人员2Байду номын сангаас0人
恒瑞主要从事抗肿瘤药、心血管类药、镇痛类药、 抗生素的生产。
2003、2004年抗肿瘤药销量全国排名第一。
Hengrui Group
Jiangsu Hengrui Medicine Co., Ltd.
Pharmaceuticals and R&D
Shanghai Hengrui Medicine Co., Ltd.
Polypeptide Synthesis
合作研究 R&D Cooperation
• 与美国Chiron公司合作研究 Cooperation Development with Chiron in USA : Eg5
• 与瑞典Medvir公司研究治疗 Cooperation with Medvir Co., in Sweden for Development of COPD Medicine
Main Businesses Line
Hengrui mainly produces antineoplastics, cardiovascular, analgesic, antibiotics . Hengrui was the No. 1 Antineoplastic sales in China Market in 2003、2004.
开发区新厂区占地3万多平方米，新建了符合GMP要求 的制剂车间，并已引进了一批国外的先进设备仪器，新增年 产针剂5000万支、冻干粉针200万瓶、灭菌分装粉针200万 瓶的生产能力。
Capacity of Jiangsu Hengrui
50 million injections, 2 million lyophilized powders 2 million sterile split charging powder. 500 million troches 12 million transfusion bags
Production, Generic Medicines • 恒瑞上海研究中心 Shnaghai R&D Center
人员Researcher and Engineer：60 Persons 药物设计、化学合成、制剂研究、生物工程 Drug Design ,Chemical Synthesizing, Preparation Improvement, Biology Engineering
年生产能力为西药20种16亿片，化学原料药40种50吨。
Head office
Workshop & Equipment
GMP固体制剂车间 Solid Preparation
Workshop & Equipment
The new factory has an area of 30 thousand of square meters, which built preparation workshops according to GMP, and imported a batch of advanced equipment and production line. Now the factory is capable of producing 50 million injections, 2 million lyophilized powders and 2 million sterile split charging powder.
R & D Activity 研究
化学药物 Chemical Medicine:
• COX-2抑制剂 Inhibitor BNP909 in Phase I BNP811 in Preclinical 糖尿病PPARγ激动剂 Diabetes PPARγAgonist 抗肿瘤药物 Antineoplastics 胃动力药 Gastrokinetic agents 抗生素 Antibiotics